Opportunity Information: Apply for RFA CA 23 024
The Limited Competition: Cooperative Human Tissue Network (CHTN; UM1 Clinical Trial Not Allowed) funding opportunity (RFA-CA-23-024) is a National Cancer Institute (NCI), National Institutes of Health (NIH) notice that supports the continued operation of the Cooperative Human Tissue Network through cooperative agreement awards (UM1 mechanism). It is a "limited competition" because it is specifically aimed at competing continuation applications from current NCI-supported CHTN awardees rather than opening the competition broadly to entirely new organizations. In practical terms, NCI is looking to renew and maintain the existing national infrastructure that makes the CHTN function as a coordinated, multi-division biospecimen resource.
The central purpose of the CHTN is to prospectively collect and distribute high-quality human tissue specimens that researchers request for basic and translational cancer research. What makes CHTN distinct is the emphasis on prospective, investigator-driven collection: tissues are obtained in response to specific scientific needs rather than being limited to what happens to be available in a bank. The specimens supported under this program include a wide range of tissue types relevant to cancer and related biology, including pre-cancerous lesions, malignant tumors, benign neoplastic tissues, tissues affected by non-neoplastic diseases, and normal tissues (including uninvolved or normal-adjacent tissue when available). These materials are intended to accelerate scientific discovery and enable development and validation of molecular diagnostic tests as well as prognostic and predictive assays.
The NOFO describes the CHTN as a national resource made up of multiple recipient sites referred to as CHTN Divisions, which collectively form the Network; at the time of the announcement, the network structure consists of six divisions. Since the CHTN was established by NCI in 1987, it has distributed more than 1,350,000 high-quality tissue specimens spanning many organ sites to over four thousand investigators, illustrating both the scale of operations and the breadth of research supported. The expectation embedded in the continuation competition is that awardees will keep delivering this kind of reliable, high-volume, high-quality biospecimen procurement and distribution service to the broader research community.
From an administrative standpoint, the award type is a cooperative agreement, meaning NCI anticipates substantial scientific or programmatic involvement in how the resource is run compared with a standard research project grant. The opportunity is explicitly marked "Clinical Trial Not Allowed," which signals that the award is intended to support the biospecimen resource and associated operations rather than clinical trial execution. The funding instrument is categorized as discretionary, and the activity area is listed under education and health. The CFDA (assistance listing) numbers associated with the opportunity are 93.393, 93.394, and 93.396. The posted award ceiling is $800,000, and the original application due date listed is 2023-07-07, with a creation date of 2023-05-31.
Eligibility in the source listing is broad across many U.S.-based organization types, including state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized tribal governments and certain tribal organizations; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; and small businesses. The notice also highlights additional eligible categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions. At the same time, it clearly restricts foreign participation: non-U.S. entities (foreign organizations and foreign institutions) are not eligible to apply; non-domestic components of U.S. organizations are not eligible; and foreign components, as defined by NIH policy, are not allowed.
Overall, the opportunity is designed to preserve and strengthen a long-running NCI-supported national biospecimen pipeline by renewing existing CHTN divisions under a UM1 cooperative agreement framework, ensuring investigators can continue to obtain tailored, high-quality human tissue specimens for cancer-related discovery, translational studies, and assay development.Apply for RFA CA 23 024
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Limited Competition: Cooperative Human Tissue Network (CHTN; UM1 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393, 93.394, 93.396.
- This funding opportunity was created on 2023-05-31.
- Applicants must submit their applications by 2023-07-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $800,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed)
Previous opportunity: FY 2023 Competitive Funding Opportunity: Airport Improvement Program Discretionary Grants
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 23 024
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 23 024) also looked into and applied for these:
| Funding Opportunity |
|---|
| Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional) Apply for RFA HG 23 017 Funding Number: RFA HG 23 017 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Leveraging Social Networks to Promote Widespread Individual Behavior Change (R01 Clinical Trial Optional) Apply for RFA AG 24 025 Funding Number: RFA AG 24 025 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Leveraging Social Networks to Promote Widespread Individual Behavior Change (R34 Clinical Trial Optional) Apply for RFA AG 24 026 Funding Number: RFA AG 24 026 Agency: National Institutes of Health Category: Education, Health Funding Amount: $225,000 |
| NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) Apply for PAR 23 178 Funding Number: PAR 23 178 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed) Apply for PAR 23 194 Funding Number: PAR 23 194 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| The Blood and Marrow Transplant Clinical Trials Network - Data Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA HL 24 011 Funding Number: RFA HL 24 011 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| The Blood and Marrow Transplant Clinical Trials Network - Core Clinical Centers (UG1 Clinical Trial Optional) Apply for RFA HL 24 010 Funding Number: RFA HL 24 010 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Advancing Cancer Control Equity Research through Transformative Solutions Coordination Center (U24 Clinical Trial Optional) Apply for RFA CA 23 027 Funding Number: RFA CA 23 027 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Advancing Cancer Control Equity Research Through Transformative Solutions (U19 Clinical Trial Optional) Apply for RFA CA 23 026 Funding Number: RFA CA 23 026 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,500,000 |
| Limited Competition: NIH-DoD-VA Pain Management Collaboratory - Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA AT 24 002 Funding Number: RFA AT 24 002 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,300,000 |
| ADVANCE Predoctoral T32 Training Program to Promote Diversity in Health Disparities Research, Preventive Interventions, and Methodology (T32, Clinical Trial Not Allowed) Apply for RFA OD 23 018 Funding Number: RFA OD 23 018 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) Apply for PA 23 231 Funding Number: PA 23 231 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Next Generation Chemistry Centers for Fusion Oncoproteins (UM1 Clinical Trial Not Allowed) Apply for RFA CA 23 037 Funding Number: RFA CA 23 037 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,500,000 |
| Mechanisms of Fusion-Driven Oncogenesis in Childhood Cancers (U01 Clinical Trial Not Allowed) Apply for RFA CA 23 036 Funding Number: RFA CA 23 036 Agency: National Institutes of Health Category: Education, Health Funding Amount: $325,000 |
| NIH-DoD-VA Pain Management Collaboratory ? Pragmatic and/or Implementation Science Demonstration Projects ((UG3/UH3) Clinical Trial Required) Apply for RFA AT 24 004 Funding Number: RFA AT 24 004 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Microglial Pathophysiology in Comorbid Substance Use Disorder (SUD) and HIV (R61/R33 Clinical Trial Not Allowed) Apply for RFA DA 25 014 Funding Number: RFA DA 25 014 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed) Apply for PAR 23 246 Funding Number: PAR 23 246 Agency: National Institutes of Health Category: Education, Health Funding Amount: $475,000 |
| Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial optional) Apply for RFA DA 25 020 Funding Number: RFA DA 25 020 Agency: National Institutes of Health Category: Education, Health Funding Amount: $450,000 |
| Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial required) Apply for RFA DA 25 019 Funding Number: RFA DA 25 019 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Addressing HIV in highest risk sexual and gender minorities (R34 Clinical Trial Required) Apply for RFA DA 25 002 Funding Number: RFA DA 25 002 Agency: National Institutes of Health Category: Education, Health Funding Amount: $225,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 23 024", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.